VJOncology is committed to improving our service to you

ASCO 2020 | CheckMate-743 study in mesothelioma

VJOncology is committed to improving our service to you

Dean Fennell

Dean Fennell, PhD, FRCP, of the University Hospitals Of Leicester NHS Trust, Leicester, UK discusses the result of the CheckMate-743 study (NCT02899299) which evaluated the efficacy of nivolumab combined with ipilimumab versus pemetrexed and cisplatin or carboplatin as first line therapy in unresectable pleural mesothelioma patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter